Can weekly texts stop wasting in kids exposed to HIV?

NCT ID NCT06842732

Recruiting now Disease control Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a simple text-message system can help caregivers in Kenya spot and prevent malnutrition in children exposed to HIV. About 776 caregiver-child pairs will be split into two groups: one gets weekly SMS reminders to measure the child's arm and receive feeding tips, while the other gets standard care. The goal is to see if the SMS group has fewer cases of wasting, faster recovery, and fewer hospitalizations over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Two-way SMS platform with nutrition education and caregiver-led mid-upper arm circumference (MUAC) monitoring
What this could lead to: If it works, this could offer a low-cost, scalable way to prevent malnutrition and reduce hospitalizations in vulnerable children.
What could go wrong: This is a behavioral intervention, not a drug or cure. Success depends on caregiver engagement and phone access, and results may not apply outside Kenya.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDREN EXPOSED TO HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cachexia Child Nutrition Disorders HIV infectious disease nutritional deficiency disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILDREN EXPOSED TO HIV MALNUTRITION IN CHILDREN

Contacts and locations

Locations

Homa Bay County Referral Hospital
RECRUITING

Homa Bay, Kenya
Migori County Referral Hospital
RECRUITING

Migori, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.